1.
Am J Hematol
; 97(8): E312-E317, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35702878
2.
Platelets
; 33(4): 652-653, 2022 May 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35225144
RESUMO
In 2021, the world experienced the most extensive vaccination campaign to defeat COVID-19. Many cases of idiopathic thrombocytopenia have been reported following injections of SARS-Cov-2 mRNA vaccine. We present the case of a 73-year-old woman with de novo ITP after a first injection of SARS-Cov-2 mRNA vaccine (Moderna vaccine) who experienced a successful rechallenge of SARS-Cov-2 mRNA vaccine (Pfizer vaccine) a few months later.